Yahoo Web Search

Search results

    • Tumors shrink for 62% of patients in Merck study

      Becker’s Hospital Review· 1 day ago

      In a phase 2/3 trial investigating the efficacy of Keytruda with two chemotherapies, tumors shrank among 3 in 5 patients with pleural mesothelioma, Merck said May 29. It often progresses rapidly ...